103 related articles for article (PubMed ID: 31966448)
1. Bone morphogenetic protein 9 is a potential tumor suppressor in osteosarcoma.
Liang J; Zhang J; Chen F; Lian Z; Dong Y; Lu N; Jia Y
Int J Clin Exp Pathol; 2017; 10(11):11030-11036. PubMed ID: 31966448
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion.
Lv Z; Yang D; Li J; Hu M; Luo M; Zhan X; Song P; Liu C; Bai H; Li B; Yang Y; Chen Y; Shi Q; Weng Y
Mol Cells; 2013 Aug; 36(2):119-26. PubMed ID: 23807047
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.
Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y
Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein 9 facilitates osteocarcinoma cell apoptosis and inhibits in vivo tumor growth.
Zhang J; Liang JH; Huang JG
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706722
[TBL] [Abstract][Full Text] [Related]
5. miR-149 promotes human osteocarcinoma progression via targeting bone morphogenetic protein 9 (BMP9).
Xie Z; Xu J; Peng L; Gao Y; Zhao H; Qu Y
Biotechnol Lett; 2018 Jan; 40(1):47-55. PubMed ID: 28956179
[TBL] [Abstract][Full Text] [Related]
6. BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231.
Wang K; Feng H; Ren W; Sun X; Luo J; Tang M; Zhou L; Weng Y; He TC; Zhang Y
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1687-96. PubMed ID: 21892652
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway.
Liu F; Wang K; Zhang L; Yang YL
Oncol Lett; 2018 Oct; 16(4):5113-5121. PubMed ID: 30250579
[TBL] [Abstract][Full Text] [Related]
8. Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling.
Li R; Zhang W; Cui J; Shui W; Yin L; Wang Y; Zhang H; Wang N; Wu N; Nan G; Chen X; Wen S; Deng F; Zhang H; Zhou G; Liao Z; Zhang J; Zhang Q; Yan Z; Liu W; Zhang Z; Ye J; Deng Y; Luu HH; Haydon RC; He TC; Deng ZL
Curr Cancer Drug Targets; 2014; 14(3):274-85. PubMed ID: 24605944
[TBL] [Abstract][Full Text] [Related]
9. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells.
Raval P; Hsu HH; Schneider DJ; Sarras MP; Masuhara K; Bonewald LF; Anderson HC
J Dent Res; 1996 Jul; 75(7):1518-23. PubMed ID: 8876605
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of BMP9 promotes growth of osteosarcoma mediated by the Notch signaling pathway.
Liu P; Man Y; Wang Y; Bao Y
Oncol Lett; 2016 Feb; 11(2):1367-1370. PubMed ID: 26893744
[TBL] [Abstract][Full Text] [Related]
11. BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression.
Ren W; Sun X; Wang K; Feng H; Liu Y; Fei C; Wan S; Wang W; Luo J; Shi Q; Tang M; Zuo G; Weng Y; He T; Zhang Y
Mol Biol Rep; 2014 Mar; 41(3):1373-83. PubMed ID: 24413988
[TBL] [Abstract][Full Text] [Related]
12. Effect and Mechanism of
Li X; Liu LF; Liu YZ; Pan YT; Li G; Lu QY; Li ZC
Balkan Med J; 2018 Mar; 35(2):155-162. PubMed ID: 29363485
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR‑95-3p inhibits growth of osteosarcoma by targeting HDGF.
Liu X; Ma W; Ma J; Xiao L; Hao D
Pathol Res Pract; 2019 Aug; 215(8):152492. PubMed ID: 31257090
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the phosphatidylinositol 3-kinase/Akt pathway is involved in BMP9-mediated tumor-suppressive effects in gastric cancer cells.
Duan L; Ye L; Wu R; Wang H; Li X; Li H; Yuan S; Zha H; Sun H; Zhang Y; Chen X; Zhang Y; Zhou L
J Cell Biochem; 2015 Jun; 116(6):1080-9. PubMed ID: 25640278
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of 14-3-3β inhibits proliferation and migration in osteosarcoma cells.
Wu Q; Zhu J; Liu F; Liu J; Li M
Mol Med Rep; 2018 Feb; 17(2):2493-2500. PubMed ID: 29207109
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2.
Chen Y; Huang T; Yang X; Liu C; Li P; Wang Z; Zhi S
Oncol Rep; 2018 Oct; 40(4):2251-2259. PubMed ID: 30066949
[TBL] [Abstract][Full Text] [Related]
18. PTEN Plays Dual Roles As a Tumor Suppressor in Osteosarcoma Cells.
Xi Y; Chen Y
J Cell Biochem; 2017 Sep; 118(9):2684-2692. PubMed ID: 28106296
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
20. [Effect of Parkinson's disease-relevant protein DJ-1 on cell proliferation, apoptosis, invasion and migration in human osteosarcoma cells].
Li H; Hu X; Ma B; Zhang H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1054-1060. PubMed ID: 30523224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
